Skip to content
Screener

Kyverna Therapeutics, Inc. KYTX Q2 2026 earnings

Reported August 12, 2026 · After market close

EPS-$0.63Beat by $0.05
EPS estimate-$0.68

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.68

FAQ

When did Kyverna Therapeutics, Inc. report Q2 2026 earnings?
Kyverna Therapeutics, Inc. (KYTX) reported Q2 2026 earnings on August 12, 2026 after market close.
What were Kyverna Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Kyverna Therapeutics, Inc. reported eps of $-0.63 for Q2 2026.
Did Kyverna Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.68 by $0.05.
How did Kyverna Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 35.1% from $-0.97.
Where can I find Kyverna Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-344572) and the 10-Q periodic report (0001193125-26-344607) directly on SEC EDGAR. The filing index links above go to sec.gov.